Class information for:
Level 1: KETAMINE//EXPT THER EUT PATHOPHYSIOL BRANCH//INTEGRAT BIOMED BRAIN DIS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
10112 1027 56.1 83%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
677 12489 PREPULSE INHIBITION//D SERINE//D AMINO ACID OXIDASE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 KETAMINE Author keyword 58 14% 39% 399
2 EXPT THER EUT PATHOPHYSIOL BRANCH Address 20 36% 4% 45
3 INTEGRAT BIOMED BRAIN DIS Address 4 67% 0% 4
4 EXPT THER EUT MOOD ANXIETY DISORDERS PROGR Address 4 75% 0% 3
5 KETAMINE DEPENDENCE Author keyword 4 75% 0% 3
6 PEDIAT ANAESTHESIOL INTENS THER Y Address 4 75% 0% 3
7 TRANSLAT SYST BIOL NEUROSCI Address 3 57% 0% 4
8 ABRAHAM RIBICOFF IL Address 3 14% 2% 18
9 RAPID ACTING Author keyword 3 60% 0% 3
10 DMPK INFECT INNOVAT MED Address 2 67% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 KETAMINE 58 14% 39% 399 Search KETAMINE Search KETAMINE
2 KETAMINE DEPENDENCE 4 75% 0% 3 Search KETAMINE+DEPENDENCE Search KETAMINE+DEPENDENCE
3 RAPID ACTING 3 60% 0% 3 Search RAPID+ACTING Search RAPID+ACTING
4 RAPID ACTING ANTIDEPRESSANT 2 67% 0% 2 Search RAPID+ACTING+ANTIDEPRESSANT Search RAPID+ACTING+ANTIDEPRESSANT
5 THERAPY RESISTANT UNIPOLAR DEPRESSION 2 67% 0% 2 Search THERAPY+RESISTANT+UNIPOLAR+DEPRESSION Search THERAPY+RESISTANT+UNIPOLAR+DEPRESSION
6 AMPA RECEPTOR POTENTIATORS 2 50% 0% 3 Search AMPA+RECEPTOR+POTENTIATORS Search AMPA+RECEPTOR+POTENTIATORS
7 LY392098 2 43% 0% 3 Search LY392098 Search LY392098
8 CLINICAL AND PHARMACOKINETIC STUDIES 1 100% 0% 2 Search CLINICAL+AND+PHARMACOKINETIC+STUDIES Search CLINICAL+AND+PHARMACOKINETIC+STUDIES
9 LANICEMINE 1 100% 0% 2 Search LANICEMINE Search LANICEMINE
10 NMDA N METHYL D ASPARTATE RECEPTORS 1 50% 0% 2 Search NMDA+N+METHYL+D+ASPARTATE+RECEPTORS Search NMDA+N+METHYL+D+ASPARTATE+RECEPTORS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 D ASPARTATE ANTAGONIST 78 34% 18% 189
2 K HOLE 38 93% 1% 14
3 RESISTANT MAJOR DEPRESSION 29 37% 6% 64
4 ULCERATIVE CYSTITIS 27 78% 2% 18
5 SUBANESTHETIC KETAMINE 25 60% 3% 27
6 ADD ON TRIAL 25 36% 5% 55
7 RAPID ANTIDEPRESSANT RESPONSE 16 58% 2% 19
8 NMDA RECEPTOR HYPOFUNCTION 9 19% 4% 44
9 NMDA RECEPTOR BLOCKADE 9 24% 3% 32
10 BIPOLAR DEPRESSION 8 15% 5% 50

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes 2015 6 37 70%
Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics 2015 4 96 63%
Glutamate Receptor Antagonists as Fast-Acting Therapeutic Alternatives for the Treatment of Depression: Ketamine and Other Compounds 2014 16 116 66%
A review of ketamine in affective disorders: Current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action 2014 16 97 64%
Ketamine as a novel treatment for major depressive disorder and bipolar depression: a systematic review and quantitative meta-analysis 2015 2 52 79%
Ketamine administration in depressive disorders: a systematic review and meta-analysis 2014 15 21 62%
Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond 2013 47 95 56%
Synaptic Dysfunction in Depression: Potential Therapeutic Targets 2012 152 50 36%
Towards a glutamate hypothesis of depression An emerging frontier of neuropsychopharmacology for mood disorders 2012 163 205 26%
Glutamate-based antidepressants: 20 years on 2009 189 61 41%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 EXPT THER EUT PATHOPHYSIOL BRANCH 20 36% 4.4% 45
2 INTEGRAT BIOMED BRAIN DIS 4 67% 0.4% 4
3 EXPT THER EUT MOOD ANXIETY DISORDERS PROGR 4 75% 0.3% 3
4 PEDIAT ANAESTHESIOL INTENS THER Y 4 75% 0.3% 3
5 TRANSLAT SYST BIOL NEUROSCI 3 57% 0.4% 4
6 ABRAHAM RIBICOFF IL 3 14% 1.8% 18
7 DMPK INFECT INNOVAT MED 2 67% 0.2% 2
8 MED PSYCHOLUOC PSYCHIAT 2 67% 0.2% 2
9 NEUROPSYCHOPHARMACOL FUNCT NEUROGENOM 2 67% 0.2% 2
10 MOL PSYCHIAT GENES BEHAV 2 50% 0.3% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000165995 SECT CLIN MOL PSYCHOBIOL//NEURONAL NITRIC OXIDE SYNTHASE NOS1//PSYCHOSOCIAL GENOMICS
2 0.0000144895 OPIOID INDUCED HYPERALGESIA//KETAMINE//S KETAMINE
3 0.0000136462 N ACETYL ASPARTATE//N ACETYLASPARTATE//MOL DYNAM MENTAL DISORDERS
4 0.0000132262 PHENCYCLIDINE//METAPHIT//CAS 956 90 1
5 0.0000129891 GLYT1//GLYCINE TRANSPORTER//GLYT 1
6 0.0000128774 PROGRAM STRUCT MOL NEUROSCI//STRUCT NEUROSCI//PERFORANT PATH DENTATE GYRUS PATHWAY
7 0.0000114593 RILUZOLE//2 CYCLOPROPYLIMINO 3 METHYL 1 3 THIAZOLINE HYDROCHLORIDE//ANTIGLUTAMATE
8 0.0000094797 ZINC EFFLUX FROM LYMPHOCYTES//RENIN PLASMA ACTIVITY//QUIM CIENCIA AMBIENTAL
9 0.0000078397 CGP 43487//L TRANS PYRROLIDINE 3 4 DICARBOXYLIC ACID//NEUROCYTOL RD29
10 0.0000076123 TIANEPTINE//ETHANOL WITHDRAWAL SYNDROME//CAS 66981 73 5